Results 101 to 110 of about 68,966 (291)

Polycystic ovary syndrome and chronic pain among females and individuals of childbearing age: A scoping review

open access: yesSAGE Open Medicine
Objectives: The purpose of this scoping review is to explore research studies on the association between chronic pain and polycystic ovary syndrome to create local (U.S.-based) and global recommendations to improve access to and quality of affordable ...
Lea Sacca   +7 more
doaj   +1 more source

Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance

open access: yesБюллетень сибирской медицины, 2018
Aim. Polycystic ovary syndrome is a common cause of infertility. In addition, polycystic ovary syndrome is often associated with metabolic complications. In most women hyperandrogenic manifestations occur during puberty.
E. M. Bogatyreva, G. A. Novik
doaj   +1 more source

Epidemiology, diagnosis, and management of polycystic ovary syndrome

open access: yes, 2013
Susan M Sirmans, Kristen A PateDepartment of Clinical and Administrative Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USAAbstract: Polycystic ovary syndrome (PCOS) is a common heterogeneous endocrine disorder ...
Sirmans SM, Pate KA
core  

Beyond Joint Hypermobility: Investigating Bladder Dysfunction in Hypermobile Ehlers‐Danlos Syndrome

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction and Objectives Hypermobile Ehlers‐Danlos Syndrome (hEDS) is the most common subtype of Ehlers‐Danlos Syndrome, a group of connective tissue disorders caused by collagen abnormalities. While musculoskeletal features of hEDS are well characterized, its impact on visceral organs, including the bladder, remains underexplored.
Marium Ansari   +5 more
wiley   +1 more source

A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS

open access: yesWomen's Health
Polycystic ovary syndrome is a common reproductive endocrine condition that affects women of fertile age and is characterized by three main features, including hyperandrogenism, chronic anovulation, and polycystic ovaries. In addition, half of women with
Salwa Bader   +3 more
doaj   +1 more source

Awareness of Females regarding Polycystic Ovarian Syndrome at Outpatient Clinics in Minya Health Insurance Hospital [PDF]

open access: yesHelwan International Journal for Nursing Research and Practice
Background: Polycystic Ovary Syndrome (PCOS) is a hormonal disorder common among females of reproductive age. The most clinical symptoms are irregular periods infrequent, irregular or prolonged menstrual cycles, excess facial and body hair, and ...
Eslam Ali
doaj   +1 more source

Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: A pilot study

open access: yes, 2011
Polycystic ovary syndrome (PCOS) is associated with endothelial dysfunction, which may be caused by elevated levels of asymmetric dimethylarginine (ADMA).
P. J. Hardiman   +12 more
core   +1 more source

Use of Glucagon‐Like Peptide‐1 Receptor Agonists in Danish Adolescents and Young Adults 2018–2025

open access: yesObesity, EarlyView.
ABSTRACT Objective Use of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) has increased rapidly following approval for obesity treatment, but data on their use in younger populations remain limited. We examined trends in GLP‐1RA use among 12– to 24‐year‐olds in Denmark during 2018–2025.
Helene Kildegaard   +4 more
wiley   +1 more source

Lack of adequate counseling about pregnancy complications in patients with polycystic ovary syndrome: a cross-sectional survey study

open access: yesF&S Reports
Objective: To assess the counseling experiences of patients with polycystic ovary syndrome (PCOS) related to obstetric complications and preconception management of comorbidities. Design: Cross-sectional survey study. Setting: Not applicable. Patient(s):
Anne E. Kim, M.D.   +3 more
doaj   +1 more source

SURMOUNT‐REAL UK: A Pragmatic Randomized Clinical Trial to Assess the Effectiveness of Tirzepatide in Adults With Obesity

open access: yesObesity, EarlyView.
ABSTRACT Objective SURMOUNT‐REAL UK will evaluate the effectiveness of tirzepatide when offered in addition to standard‐of‐care (SoC) in adults with Class I obesity (BMI ≥ 30 and ≤ 34.9 kg/m2) and without diabetes in a UK primary care setting. Methods A 5‐year, phase 4, multicenter, open‐label, pragmatic randomized clinical trial is enabled through ...
Martin K. Rutter   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy